Health ❯Healthcare ❯Pharmaceuticals ❯Weight Loss Drugs

Mounjaro

Lilly’s Orforglipron Pill Hits Phase 3 Goals and Outperforms Oral Semaglutide in Diabetes Study

Analysts say the once-daily small‑molecule pill could qualify for a new FDA voucher that speeds reviews to one or two months.

Mounjaro NHS Rollout Stalls With Fewer Than Half of ICBs Prescribing

Lilly Pauses UK Mounjaro Shipments Ahead of Price Rise as Pharmacies Report Shortages

Mounjaro Price Hike Triggers Stockpiling and Shift to Ozempic and Wegovy

Eli Lilly to Raise UK Mounjaro Prices by Up to 170% in September

NHS Empowers GPs to Prescribe Mounjaro for Severe Obesity

NHS to Expand GP Prescriptions of Mounjaro for Weight Loss

Health Secretary Urges Faster NHS Rollout of Weight-Loss Injections